Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Justin Kim is an analyst at Oppenheimer. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 07/07/2024
| Buy Now | Get Alert | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 07/03/2024 | PHVS | Buy Now | Pharvaris | $16.65 | 128.23% | $36 → $38 | Maintains | Outperform | Get Alert |
| 05/09/2024 | CYTK | Buy Now | Cytokinetics | $56.67 | 87.05% | $107 → $106 | Maintains | Outperform | Get Alert |
| 03/04/2024 | CYTK | Buy Now | Cytokinetics | $56.67 | 88.81% | → $107 | Reiterates | Outperform → Outperform | Get Alert |
| 02/29/2024 | IMCR | Buy Now | Immunocore Hldgs | $37.46 | 132.25% | $85 → $87 | Reiterates | Outperform → Outperform | Get Alert |
| 01/30/2024 | APLS | Buy Now | Apellis Pharmaceuticals | $37.01 | 113.46% | $75 → $79 | Maintains | Outperform | Get Alert |
| 01/25/2024 | VERA | Buy Now | Vera Therapeutics | $35.98 | -27.74% | → $26 | Initiates | → Outperform | Get Alert |
| 12/15/2023 | APLS | Buy Now | Apellis Pharmaceuticals | $37.01 | 102.65% | $88 → $75 | Maintains | Outperform | Get Alert |
| 10/17/2023 | ALDX | Buy Now | Aldeyra Therapeutics | $3.31 | — | — | Downgrade | Outperform → Perform | Get Alert |
| 09/21/2023 | IMCR | Buy Now | Immunocore Hldgs | $37.46 | 126.91% | $75 → $85 | Maintains | Outperform | Get Alert |
| 08/25/2023 | ZURA | Buy Now | Zura Bio | $3.63 | 368.32% | → $17 | Initiates | → Outperform | Get Alert |
| 08/23/2023 | APLS | Buy Now | Apellis Pharmaceuticals | $37.01 | — | — | Reiterates | Outperform → Outperform | Get Alert |
| 08/11/2023 | IMCR | Buy Now | Immunocore Hldgs | $37.46 | 100.21% | $72 → $75 | Maintains | Outperform | Get Alert |
| 08/09/2023 | ALDX | Buy Now | Aldeyra Therapeutics | $3.31 | 322.96% | → $14 | Reiterates | Outperform → Outperform | Get Alert |
| 05/16/2023 | CYTK | Buy Now | Cytokinetics | $56.67 | -4.71% | → $54 | Reiterates | Outperform → Outperform | Get Alert |
| 05/12/2023 | APLS | Buy Now | Apellis Pharmaceuticals | $37.01 | 191.81% | $96 → $108 | Maintains | Outperform | Get Alert |
| 03/01/2023 | CYTK | Buy Now | Cytokinetics | $56.67 | -4.71% | $55 → $54 | Maintains | Outperform | Get Alert |
| 02/28/2023 | KDNY | Buy Now | Chinook Therapeutics | — | — | $33 → $34 | Maintains | Outperform | Get Alert |
| 02/21/2023 | KDNY | Buy Now | Chinook Therapeutics | — | — | $28 → $33 | Maintains | Outperform | Get Alert |
| 02/15/2023 | IMCR | Buy Now | Immunocore Hldgs | $37.46 | 92.21% | $65 → $72 | Maintains | Outperform | Get Alert |
| 11/18/2022 | PRVB | Buy Now | Provention Bio | — | — | $14 → $18 | Maintains | Outperform | Get Alert |
| 11/04/2022 | AUPH | Buy Now | Aurinia Pharmaceuticals | $5.63 | — | — | Downgrade | Outperform → Perform | Get Alert |
| 08/23/2022 | PHVS | Buy Now | Pharvaris | $16.65 | 32.13% | $48 → $22 | Maintains | Outperform | Get Alert |
| 08/18/2022 | APLS | Buy Now | Apellis Pharmaceuticals | $37.01 | 110.75% | $68 → $78 | Maintains | Outperform | Get Alert |
| 08/08/2022 | BCRX | Buy Now | BioCryst Pharma | $6.42 | — | — | Downgrade | Outperform → Perform | Get Alert |
| 08/08/2022 | AUPH | Buy Now | Aurinia Pharmaceuticals | $5.63 | 130.91% | $15 → $13 | Maintains | Outperform | Get Alert |
| 08/05/2022 | BCRX | Buy Now | BioCryst Pharma | $6.42 | — | — | Downgrade | Outperform → Perform | Get Alert |
| 07/18/2022 | IONS | Buy Now | Ionis Pharmaceuticals | $47.24 | 24.89% | → $59 | Assumes | → Outperform | Get Alert |
| 06/30/2022 | ANGN | Buy Now | Angion Biomedica | — | — | — | Downgrade | Outperform → Perform | Get Alert |
| 04/11/2022 | BCRX | Buy Now | BioCryst Pharma | $6.42 | 149.22% | $20 → $16 | Maintains | Outperform | Get Alert |
| 12/22/2021 | CYTK | Buy Now | Cytokinetics | $56.67 | -2.95% | → $55 | Initiates | → Outperform | Get Alert |
| 12/10/2021 | ANGN | Buy Now | Angion Biomedica | — | — | — | Maintains | Outperform | Get Alert |
| 12/10/2021 | AUPH | Buy Now | Aurinia Pharmaceuticals | $5.63 | 450.62% | — | Upgrade | Perform → Outperform | Get Alert |
| 12/10/2021 | BCRX | Buy Now | BioCryst Pharmaceuticals | $6.42 | 149.22% | — | Initiates | → Outperform | Get Alert |
